Gilead Sciences' Livdelzi Helps More Patients With Bile Duct Disease Improve Liver Marker Levels

Data ReadoutpositiveLivdelziPositive

AI Analysis

Summary

Gilead Sciences reported that Livdelzi demonstrated efficacy in helping patients with bile duct disease improve liver marker levels. The positive data supports the drug's therapeutic potential for this indication.

Outcome Details

Livdelzi helps more patients with bile duct disease improve liver marker levels

Importance:5/10

Sentiment:

0.60

Livdelzibile duct diseaseliver markersclinical data

Related Companies

$GILD

Read the original article

Published by yahoo_finance on June 2, 2026 1:10 PM

Read Original